<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03629392</url>
  </required_header>
  <id_info>
    <org_study_id>239948-B</org_study_id>
    <nct_id>NCT03629392</nct_id>
  </id_info>
  <brief_title>Methionine and Cysteine Restriction in Humans</brief_title>
  <official_title>Dietary Methionine and Cysteine Restriction in Overweight Human Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oslo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Research Council of Norway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Oxford</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Oslo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to examine the effect of methionine and cysteine restriction on
      energy and macronutrient metabolism in overweight human subjects
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The sulfur-containing amino acid methionine and its downstream metabolite cysteine has been
      associated with fat mass in animal studies and human observational studies. Some of the
      proposed mechanisms include an association with lipogenesis, insulin sensitivity and
      disrupted energy metabolism.

      The overall aim of this project is to evaluate the effects of a diet low in methionine and
      cysteine on markers of lipids, amino acids, glucose and other biomarkers related to energy
      metabolism, including transcriptomic and protein expression data from adipose tissue and
      lymphocytes. Overweight and obese but otherwise healthy volunteers will be randomized to
      receive a diet either low, moderate or high in methionine and cysteine concentrations for 1
      week.

      This is a pilot study that may be considered an extension of NCT02647970. In addition to the
      primary and secondary outcomes we will evaluate the feasibility of the intervention and
      procedures.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 8, 2018</start_date>
  <completion_date type="Actual">December 11, 2018</completion_date>
  <primary_completion_date type="Actual">December 11, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Participant: The diets are similar except for methionine and cysteine, and it is thought that the participants will not be able to identify their treatment allocation by taste.
Investigator: Randomization will be carried out by an investigator that is not related to the study. All foods will be pre-packaged and delivered to the participants by an unrelated company.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in plasma concentrations of amino acids</measure>
    <time_frame>Baseline, Day 1, Day 3 and Day 7 (final visit)</time_frame>
    <description>Measurement of biomarkers of amino acid metabolism, including plasma concentrations of methionine, cysteine and related metabolites</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in protein expression activity in tissues</measure>
    <time_frame>Baseline and day 7 (final visit for adipose tissue, Baseline and day 1, 3 and 7 (final visit) for lymphocytes.</time_frame>
    <description>Measurement of protein expression and activity related to methionine and cysteine metabolism in adipose tissue and lymphocytes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in plasma concentrations of fatty acids</measure>
    <time_frame>Baseline, Day 1, Day 3 and Day 7 (final visit)</time_frame>
    <description>Measurement of fatty acid content in plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in plasma activity indices of steaoryl-CoA desaturase</measure>
    <time_frame>Baseline, Day 1, Day 3 and Day 7 (final visit)</time_frame>
    <description>Calculated based onthe ratio of plasma concentrations of products and precursors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in protein expression of steaoryl CoA-desaturase in adipose tissue</measure>
    <time_frame>Baseline and Day 7 (final visit)</time_frame>
    <description>Measurement of protein expression of steaoryl CoA-desaturase in adipose tissue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in protein expression of steaoryl CoA-desaturase in lymphocytes</measure>
    <time_frame>Baseline, Day 1, Day 3 and Day 7 (final visit)</time_frame>
    <description>Measurement of protein expression of steaoryl CoA-desaturase in lymphocytes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in steaoryl CoA-desaturase activity in adipose tissue</measure>
    <time_frame>Baseline and Day 7 (final visit)</time_frame>
    <description>Measurement of enzyme activity of steaoryl CoA-desaturase in adipose tissue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diet feasibility</measure>
    <time_frame>Baseline, Day 1, Day 3 and Day 7 (final visit)</time_frame>
    <description>Diet feasibility will be measured by a self-administered questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diet compliance</measure>
    <time_frame>Baseline, Day 1, Day 3 and Day 7 (final visit)</time_frame>
    <description>Compliance with the diet will be measured by a self-administered questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>Baseline and day 7 (final visit)</time_frame>
    <description>Measurement of body composition by bioimpedance and dual X-ray absorptometry</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">19</enrollment>
  <condition>Overweight</condition>
  <arm_group>
    <arm_group_label>Low met/cys diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dietary intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Moderate met/cys diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dietary intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High met/cys diet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dietary intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low met/cys diet</intervention_name>
    <description>Dietary intervention with low contents of methionine and cysteine</description>
    <arm_group_label>Low met/cys diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Moderate met/cys diet</intervention_name>
    <description>Dietary intervention with moderate contents of methionine and cysteine</description>
    <arm_group_label>Moderate met/cys diet</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>High met/cys diet</intervention_name>
    <description>Dietary intervention with high contents of methionine and cysteine</description>
    <arm_group_label>High met/cys diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body mass index of 25-35 kg/m2

        Exclusion Criteria:

          -  High physical activity

          -  Smoking

          -  Drugs

          -  Chronic disease

          -  Pregnancy or breastfeeding
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Oslo</name>
      <address>
        <city>Oslo</city>
        <zip>0372</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <results_reference>
    <citation>Olsen T, Øvrebø B, Haj-Yasein N, Lee S, Svendsen K, Hjorth M, Bastani NE, Norheim F, Drevon CA, Refsum H, Vinknes KJ. Effects of dietary methionine and cysteine restriction on plasma biomarkers, serum fibroblast growth factor 21, and adipose tissue gene expression in women with overweight or obesity: a double-blind randomized controlled pilot study. J Transl Med. 2020 Mar 11;18(1):122. doi: 10.1186/s12967-020-02288-x.</citation>
    <PMID>32160926</PMID>
  </results_reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>August 2, 2018</study_first_submitted>
  <study_first_submitted_qc>August 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2018</study_first_posted>
  <last_update_submitted>March 23, 2020</last_update_submitted>
  <last_update_submitted_qc>March 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Oslo</investigator_affiliation>
    <investigator_full_name>Kathrine Vinknes</investigator_full_name>
    <investigator_title>Kathrine Vinknes, PhD</investigator_title>
  </responsible_party>
  <keyword>Methionine</keyword>
  <keyword>Cysteine</keyword>
  <keyword>Energy metabolism</keyword>
  <keyword>Sulfur amino acids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

